avb6 Integrin- A marker for the malignant potential of epithelial ovarian cancer […]Read More… from avb6 Integrin- A marker for the malignant potential of epithelial ovarian cancer
Neuronal transcription factor Brn-3a is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer. […]Read More… from Neuronal transcription factor Brn-3a is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer.
Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of a6b1 integrin. […]Read More… from Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of a6b1 integrin.
Cross talk of signals between EGFR and IL-6R via JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. […]Read More… from Cross talk of signals between EGFR and IL-6R via JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
Epithelial-Mesenchymal interconversions in normal ovarian epithelium and ovarian carcinomas: an exception to the norm […]Read More… from Epithelial-Mesenchymal interconversions in normal ovarian epithelium and ovarian carcinomas: an exception to the norm
Immunohistochemical perspective of PPARb and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours […]Read More… from Immunohistochemical perspective of PPARb and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. […]Read More… from Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
a2b1 integrin affects metastatic ability of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. […]Read More… from a2b1 integrin affects metastatic ability of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
Proteomics tracking of serum protein isoforms as screening biomarkers of ovarian cancer. […]Read More… from Proteomics tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix micro-environment. […]Read More… from Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix micro-environment.
Ascites induces modulation of a6 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. […]Read More… from Ascites induces modulation of a6 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
Enhanced expression of peroxisome proliferator receptor g expression in ovarian carcinoma. […]Read More… from Enhanced expression of peroxisome proliferator receptor g expression in ovarian carcinoma.
Proteomics based identification of hatoglobin-1 precursor as a novel circulating biomarker for ovarian cancer. […]Read More… from Proteomics based identification of hatoglobin-1 precursor as a novel circulating biomarker for ovarian cancer.
Cell-free 59 kDa Immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma. […]Read More… from Cell-free 59 kDa Immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma.
Expression and localization of avb6 integrin in extraplacental fetal membranes: possible role in human parturition. […]Read More… from Expression and localization of avb6 integrin in extraplacental fetal membranes: possible role in human parturition.
Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. […]Read More… from Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
Multicellular spheroids in ovarian cancer metastases: Biology and pathology. […]Read More… from Multicellular spheroids in ovarian cancer metastases: Biology and pathology.
Overexpression of avb6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. […]Read More… from Overexpression of avb6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer […]Read More… from Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer
Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment […]Read More… from Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment
Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer […]Read More… from Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer […]Read More… from Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer
Parathyroid hormone-related protein and human papillomavirus in gynecological tumors […]Read More… from Parathyroid hormone-related protein and human papillomavirus in gynecological tumors
Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells […]Read More… from Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence […]Read More… from The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets […]Read More… from Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets […]Read More… from Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer […]Read More… from Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer
Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer […]Read More… from Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients. […]Read More… from Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients.
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism […]Read More… from Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism
Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment […]Read More… from Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells […]Read More… from TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods […]Read More… from Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer […]Read More… from The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. […]Read More… from Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer.
Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells. […]Read More… from Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells.
Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer […]Read More… from Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. […]Read More… from Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. […]Read More… from The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer. […]Read More… from Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Molecular pathways regulating epidermal growth factor-induced epithelio-mesenchymal transition in human ovarian surface epithelium. […]Read More… from Molecular pathways regulating epidermal growth factor-induced epithelio-mesenchymal transition in human ovarian surface epithelium.
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells […]Read More… from Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. […]Read More… from A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics. […]Read More… from Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics.
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling […]Read More… from Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkB-mediated induction of MMP2. […]Read More… from Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkB-mediated induction of MMP2.
Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. […]Read More… from Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden.
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden […]Read More… from Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer […]Read More… from Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets. […]Read More… from Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. […]Read More… from Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.
Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research […]Read More… from Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance […]Read More… from Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance
Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer […]Read More… from Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
Attributes of Oct4 in stem cell biology: Perspectives on cancer stem cells of the ovary […]Read More… from Attributes of Oct4 in stem cell biology: Perspectives on cancer stem cells of the ovary
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemo resistant ovarian tumors […]Read More… from Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemo resistant ovarian tumors
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profiles […]Read More… from Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profiles
2D-PAGE of Ovarian Cancer: Analysis of soluble and insoluble fractions using narrow pH ranges […]Read More… from 2D-PAGE of Ovarian Cancer: Analysis of soluble and insoluble fractions using narrow pH ranges
Effect of silencing neutrophil gelatinase-associated lipocalin in ovarian cancer cells on epithelio-mesenchymal transition. […]Read More… from Effect of silencing neutrophil gelatinase-associated lipocalin in ovarian cancer cells on epithelio-mesenchymal transition.
Ovarian CancerOvarian Cancer
Ovarian Cancer